Nuzenio

Kalkine Recce Pharmaceuticals

Kalkine Recce Pharmaceuticals news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 4 latest news signals 2 publisher sources 100/100 entity strength

Latest news

Recce Pharmaceuticals Issues Cleansing Notice Following Share Issue - KalkineKalkine · Tue, 04 Aug 2026 07:04:52 GMTRecce Pharmaceuticals Issues 250,000 Shares at $0.375 Each for Corporate Advisory Services - KalkineKalkine · Mon, 03 Aug 2026 00:42:42 GMTSuperbug Fighter Recce Pharmaceuticals (ASX:RCE) Steps Into the Global Biodefence Spotlight - KalkineKalkine · Fri, 31 Jul 2026 07:00:00 GMTRecce Pharmaceuticals to List 6,051,250 New Shares at AUD 0.40 Following Placement - Kalkine MediaKalkine Media · Fri, 31 Jul 2026 04:14:41 GMT

Timeline

Tue, 04 Aug 2026 07:04:52 GMTRecce Pharmaceuticals Issues Cleansing Notice Following Share Issue - Kalkine
Mon, 03 Aug 2026 00:42:42 GMTRecce Pharmaceuticals Issues 250,000 Shares at $0.375 Each for Corporate Advisory Services - Kalkine
Fri, 31 Jul 2026 07:00:00 GMTSuperbug Fighter Recce Pharmaceuticals (ASX:RCE) Steps Into the Global Biodefence Spotlight - Kalkine
Fri, 31 Jul 2026 04:14:41 GMTRecce Pharmaceuticals to List 6,051,250 New Shares at AUD 0.40 Following Placement - Kalkine Media

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Kalkine Recce Pharmaceuticals.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.